170 related articles for article (PubMed ID: 3139519)
41. Impairment of peripheral nervous system in patients with non-Hodgkin's lymphomas treated with CBVPM/AVBP and CHOP schedules.
Nowacki P; Dolińska D; Stankiewicz J; Grzelec H
Acta Haematol Pol; 1992; 23(2):111-6. PubMed ID: 1283282
[TBL] [Abstract][Full Text] [Related]
42. [Treatment by the CHOP protocol in malignant non-Hodgkin lymphomas with high malignancy].
Gociu M; Leahu S; Stoica I; Iofciulescu A; Berceanu S
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(1):47-51. PubMed ID: 2899347
[No Abstract] [Full Text] [Related]
43. Treatment of localized lymphoma.
Tanvetyanon T
N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15944432
[No Abstract] [Full Text] [Related]
44. [Lactic acidosis in non-Hodgkin's lymphoma].
Navigante AH; Chacón RD
Medicina (B Aires); 1985; 45(6):667-9. PubMed ID: 2431249
[No Abstract] [Full Text] [Related]
45. Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma.
Visani G; Guiducci B; D'Adamo F; Mele A; Nicolini G; Leopardi G; Sparaventi G; Barulli S; Malerba L; Isidori A; Malagola M; Piccaluga PP
Leuk Lymphoma; 2005 Mar; 46(3):477-9. PubMed ID: 15621843
[No Abstract] [Full Text] [Related]
46. [Supportive care for patients with non-Hodgkin lymphoma receiving R-CHOP chemotherapy].
Kato H
Nihon Rinsho; 2015 Feb; 73 Suppl 2():636-41. PubMed ID: 25831838
[No Abstract] [Full Text] [Related]
47. CNOP for diffuse aggressive non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience.
Vose JM; Weisenburger DD; Lynch JC; Bierman PJ; Chan JC; Bast M; Aoun P; Bociek G; Greiner T; Armitage JO;
Leuk Lymphoma; 2002 Apr; 43(4):799-804. PubMed ID: 12153167
[TBL] [Abstract][Full Text] [Related]
48. Cyclophosphamide, mitoxantrone, vincristine and prednisone in the treatment of non-Hodgkin's lymphoma.
Vorobiof DA; Terblanche AP; Falkson CI; Falkson G
Oncology; 1988; 45(5):378-9. PubMed ID: 3412747
[TBL] [Abstract][Full Text] [Related]
49. Non-Hodgkin's lymphoma in the elderly. Part 2: treatment of diffuse aggressive lymphomas.
Morrison VA
Oncology (Williston Park); 2007 Sep; 21(10):1191-8; discussion 1198-1208, 1210. PubMed ID: 17926798
[TBL] [Abstract][Full Text] [Related]
50. Full dose chemotherapy in elderly patients with non-Hodgkin's lymphoma: a feasibility study using a mitoxantrone containing regimen.
Sonneveld P; Michiels JJ
Br J Cancer; 1990 Jul; 62(1):105-8. PubMed ID: 2390469
[TBL] [Abstract][Full Text] [Related]
51. Interferon alfa plus chemotherapy for non-Hodgkin's lymphoma: five-year follow-up.
Andersen JW; Smalley RV
N Engl J Med; 1993 Dec; 329(24):1821-2. PubMed ID: 8232506
[No Abstract] [Full Text] [Related]
52. [Modified CHOP-Bleo protocol in the treatment of malignant non-Hodgkin's lymphoma of low cell differentiation].
Płuzańska A; Małecka E; Krykowski E; Olszańska-Skorek T; Stempczyńska J; Polkowska E; Hyjek E
Pol Arch Med Wewn; 1988 Dec; 80(6):323-30. PubMed ID: 2481844
[No Abstract] [Full Text] [Related]
53. [Combined (poly-chemo-radio) therapy of non-Hodgkin's lymphomas].
Baĭsogolov GD; Shakhtarina SV; Polonskaia NIu; Davydov VA
Med Radiol (Mosk); 1989 Aug; 34(8):31-6. PubMed ID: 2770444
[No Abstract] [Full Text] [Related]
54. Non-Hodgkin's lymphoma presenting with cardiac tamponade.
Gerardi DA; Hellman RM; Conlon M
Conn Med; 1992 Jan; 56(1):11-3. PubMed ID: 1547630
[TBL] [Abstract][Full Text] [Related]
55. Aggressive non-Hodgkin's lymphoma in elderly patients: where to go from here?
Obrist R
Eur J Cancer; 1994; 30A(9):1213-4. PubMed ID: 7999399
[No Abstract] [Full Text] [Related]
56. Severe lung toxicity with a weekly low dose chemotherapy regimen in patients with non-Hodgkin's lymphoma.
Quigley M; Brada M; Heron C; Horwich A
Hematol Oncol; 1988; 6(4):319-24. PubMed ID: 2460399
[TBL] [Abstract][Full Text] [Related]
57. [Diarrhea caused by Campylobacter in patients with hematologic diseases].
Fischer W; Gościniak G; Gałazka Z
Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):131-2. PubMed ID: 1437800
[TBL] [Abstract][Full Text] [Related]
58. Intensified CHOP in non-Hodgkin's lymphoma: what we know and what we need to know.
Santoro A; Balzarotti M; Castagna L
Ann Oncol; 1999 Aug; 10(8):875-6. PubMed ID: 10509145
[No Abstract] [Full Text] [Related]
59. Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481).
Wiernik PH; Moore DF; Bennett JM; Vogl SE; Harris JE; Luger S; Oken MM; Glick JH
Leuk Lymphoma; 1998 Aug; 30(5-6):601-7. PubMed ID: 9711922
[TBL] [Abstract][Full Text] [Related]
60. Non-Hodgkin's lymphoma trials in elderly look beyond CHOP.
McNeil C
J Natl Cancer Inst; 1998 Feb; 90(4):266-7. PubMed ID: 9486808
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
